Evidence map›Paper›PMID 41249737›Full record

ArticleEMBO molecular medicine2025

Evidence that G-quadruplexes form in pathogenic fungi and represent promising antifungal targets.

Georgie Middleton, Fuad O Mahamud, Isabelle S R Storer, Abigail Williams-Gunn, Finn Wostear, Alireza Abdolrasouli, Elaine Barclay, Alice Bradford, Oliver Steward, Silke Schelenz and 8 more

Abstract read
In one paragraph

Article in EMBO molecular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Innovation in antifungal therapy.EMBO molecular medicine · 2026
    Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Georgie Middleton *School of Chemistry, Pharmacy and Pharmacology, University of East Anglia, Norwich, NR4 7TJ, UK.
Fuad O Mahamud *School of Pharmacy, University College London, London, WC1N 1AX, UK.ORCID 0009-0006-3401-9617
Isabelle S R Storer *School of Chemistry, Pharmacy and Pharmacology, University of East Anglia, Norwich, NR4 7TJ, UK.ORCID 0000-0001-8717-2574
Abigail Williams-GunnSchool of Chemistry, Pharmacy and Pharmacology, University of East Anglia, Norwich, NR4 7TJ, UK.
Finn WostearSchool of Chemistry, Pharmacy and Pharmacology, University of East Anglia, Norwich, NR4 7TJ, UK.
Alireza AbdolrasouliDepartment of Microbiology, King's College Hospital NHS Foundation Trust, London, SE5 9RS, UK.
Elaine BarclayJohn Innes Centre Bioimaging Facility, Norwich Research Park, Norwich, NR4 7UH, UK.
Alice BradfordSchool of Chemistry, Pharmacy and Pharmacology, University of East Anglia, Norwich, NR4 7TJ, UK.
Oliver StewardSchool of Chemistry, Pharmacy and Pharmacology, University of East Anglia, Norwich, NR4 7TJ, UK.ORCID 0009-0002-2854-2787
Silke SchelenzSchool of Immunology and Microbial Sciences, King's College London, London, WC2R 2LS, UK.
James McCollHenry Wellcome Laboratory for Cell Imaging, University of East Anglia, Norwich, NR4 7TJ, UK.
Bertrand LézéFaculty of Science, University of East Anglia, Norwich, NR4 7TJ, UK.
Norman van RhijnManchester Fungal Infection Group, University of Manchester, Manchester, M13 9PL, UK.
Alessandra da Silva DantasSchool of Dental Sciences, Newcastle University, Newcastle, NE1 7RU, UK.ORCID 0000-0003-2795-8721
Takanori FurukawaManchester Fungal Infection Group, University of Manchester, Manchester, M13 9PL, UK.
Derek WarrenSchool of Chemistry, Pharmacy and Pharmacology, University of East Anglia, Norwich, NR4 7TJ, UK.
Zoë A E WallerSchool of Pharmacy, University College London, London, WC1N 1AX, UK. z.waller@ucl.ac.uk.ORCID 0000-0001-8538-0484
Stefan BidulaSchool of Chemistry, Pharmacy and Pharmacology, University of East Anglia, Norwich, NR4 7TJ, UK. s.bidula@uea.ac.uk.ORCID 0000-0002-3790-7138

Funding

Academy of Medical Sciences (The Academy of Medical Sciences) SBF0010\1140Academy of Medical Sciences (The Academy of Medical Sciences) SBF008\1046Royal Society (The Royal Society) RG\R2\232363UKRI | Biotechnology and Biological Sciences Research Council (BBSRC) BB/W001616/1UKRI | Biotechnology and Biological Sciences Research Council (BBSRC) BB/Y005058/1Wellcome TrustWellcome Trust (WT) 226408/Z/22/Z
6 · The paper itself

Abstract

Fungi are estimated to cause the death of almost 4 million people annually, and we urgently need new drug targets to overcome antifungal resistance. We found that four-stranded nucleic acid structures called G-quadruplexes (G4s) could form within the critical priority fungal pathogen Aspergillus fumigatus. Sequences with the potential to form G4s could be found in genes involved in fungal growth, virulence, and drug resistance. This included cyp51A, which encodes the target of azoles. Notably, we observed the formation of both canonical and unusual acid-stabilised G4s in these sequences. We found that PhenDC3 (a G4-stabilising ligand) could refold DNA into antiparallel G4 structures in cyp51A that were associated with decreased transcription. PhenDC3 also had potent fungistatic activity, prevented germination, synergised with the antifungal amphotericin B in vitro and in vivo, and displayed low genotoxicity and cytotoxicity towards human cells. Interestingly, PhenDC3 had greater antifungal activity towards the pan-azole-resistant A. fumigatus TR34/L98H isolate, and another G4-stabiliser, pyridostatin, killed multi-drug-resistant Candida auris. Taken together, G4s represent a promising target for the development of antifungals with novel mechanisms of action.

Indexed as

Antifungal AgentsAspergillus fumigatusG-QuadruplexesAminoquinolinesAnimalsCandida aurisDrug Resistance, FungalFungal ProteinsHumansPicolinic AcidsAminoquinolinesAntifungal AgentsFungal ProteinsPicolinic AcidspyridostatinAntifungalAspergillusCandidaDNAG-quadruplex

Identifiers

PMID41249737
PMCPMC12686049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.